rare case of incidentally diagnosed pulmonary inflammatory myofibroblastic tumour with dramatic response to crizotinib in a postpartum woman

Introduction: Inflammatory myofibroblastic tumours are rare neoplasms which most commonly affect children and young adults. With an intermediate malignant potential, they are typically detected in the abdomen, lung, mediastinum, head and neck, gastrointestinal tract, and genitourinary tract. Case...

Full description

Bibliographic Details
Main Authors: Jojo Yorke, Krupa Solanki, Vaishnavi Theegala, Alok Sinha, Don Asberry, Adel El Abbassi
Format: Article
Language:English
Published: SMC MEDIA SRL 2023-04-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/3626
_version_ 1797851134847614976
author Jojo Yorke
Krupa Solanki
Vaishnavi Theegala
Alok Sinha
Don Asberry
Adel El Abbassi
author_facet Jojo Yorke
Krupa Solanki
Vaishnavi Theegala
Alok Sinha
Don Asberry
Adel El Abbassi
author_sort Jojo Yorke
collection DOAJ
description Introduction: Inflammatory myofibroblastic tumours are rare neoplasms which most commonly affect children and young adults. With an intermediate malignant potential, they are typically detected in the abdomen, lung, mediastinum, head and neck, gastrointestinal tract, and genitourinary tract. Case description: We describe the case of a 33-year-old postpartum woman incidentally diagnosed with a pulmonary inflammatory myofibroblastic tumour following complaints of poorly controlled hypertension a week after caesarean section. She was ALK-negative and received an ALK inhibitor with complete resolution of the lesion. A ROS1–TFG fusion confirmed the diagnosis of an inflammatory myofibroblastic tumour after CT-guided fine needle aspiration. Discussion: This case highlights an uncommon presentation posing a diagnostic and therapeutic challenge and the potential treatment option of crizotinib.
first_indexed 2024-04-09T19:12:56Z
format Article
id doaj.art-d930ab363f564d779abbb9036751cabc
institution Directory Open Access Journal
issn 2284-2594
language English
last_indexed 2024-04-09T19:12:56Z
publishDate 2023-04-01
publisher SMC MEDIA SRL
record_format Article
series European Journal of Case Reports in Internal Medicine
spelling doaj.art-d930ab363f564d779abbb9036751cabc2023-04-06T14:29:51ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942023-04-0110.12890/2023_0036263161rare case of incidentally diagnosed pulmonary inflammatory myofibroblastic tumour with dramatic response to crizotinib in a postpartum womanJojo Yorke0Krupa Solanki1Vaishnavi Theegala2Alok Sinha3Don Asberry4Adel El Abbassi5Department of Internal Medicine, Division of Pulmonary/Critical Care, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, USADepartment of Internal Medicine, Division of Pulmonary/Critical Care, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, USADepartment of Internal Medicine, Division of Pulmonary/Critical Care, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, USADepartment of Pathology, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, USADepartment of Pathology, Highlands Pathology, Bristol, USABristol Regional Medical Center, Bristol, USAIntroduction: Inflammatory myofibroblastic tumours are rare neoplasms which most commonly affect children and young adults. With an intermediate malignant potential, they are typically detected in the abdomen, lung, mediastinum, head and neck, gastrointestinal tract, and genitourinary tract. Case description: We describe the case of a 33-year-old postpartum woman incidentally diagnosed with a pulmonary inflammatory myofibroblastic tumour following complaints of poorly controlled hypertension a week after caesarean section. She was ALK-negative and received an ALK inhibitor with complete resolution of the lesion. A ROS1–TFG fusion confirmed the diagnosis of an inflammatory myofibroblastic tumour after CT-guided fine needle aspiration. Discussion: This case highlights an uncommon presentation posing a diagnostic and therapeutic challenge and the potential treatment option of crizotinib.https://www.ejcrim.com/index.php/EJCRIM/article/view/3626pulmonary inflammatory myofibroblastic tumorhypertension
spellingShingle Jojo Yorke
Krupa Solanki
Vaishnavi Theegala
Alok Sinha
Don Asberry
Adel El Abbassi
rare case of incidentally diagnosed pulmonary inflammatory myofibroblastic tumour with dramatic response to crizotinib in a postpartum woman
European Journal of Case Reports in Internal Medicine
pulmonary inflammatory myofibroblastic tumor
hypertension
title rare case of incidentally diagnosed pulmonary inflammatory myofibroblastic tumour with dramatic response to crizotinib in a postpartum woman
title_full rare case of incidentally diagnosed pulmonary inflammatory myofibroblastic tumour with dramatic response to crizotinib in a postpartum woman
title_fullStr rare case of incidentally diagnosed pulmonary inflammatory myofibroblastic tumour with dramatic response to crizotinib in a postpartum woman
title_full_unstemmed rare case of incidentally diagnosed pulmonary inflammatory myofibroblastic tumour with dramatic response to crizotinib in a postpartum woman
title_short rare case of incidentally diagnosed pulmonary inflammatory myofibroblastic tumour with dramatic response to crizotinib in a postpartum woman
title_sort rare case of incidentally diagnosed pulmonary inflammatory myofibroblastic tumour with dramatic response to crizotinib in a postpartum woman
topic pulmonary inflammatory myofibroblastic tumor
hypertension
url https://www.ejcrim.com/index.php/EJCRIM/article/view/3626
work_keys_str_mv AT jojoyorke rarecaseofincidentallydiagnosedpulmonaryinflammatorymyofibroblastictumourwithdramaticresponsetocrizotinibinapostpartumwoman
AT krupasolanki rarecaseofincidentallydiagnosedpulmonaryinflammatorymyofibroblastictumourwithdramaticresponsetocrizotinibinapostpartumwoman
AT vaishnavitheegala rarecaseofincidentallydiagnosedpulmonaryinflammatorymyofibroblastictumourwithdramaticresponsetocrizotinibinapostpartumwoman
AT aloksinha rarecaseofincidentallydiagnosedpulmonaryinflammatorymyofibroblastictumourwithdramaticresponsetocrizotinibinapostpartumwoman
AT donasberry rarecaseofincidentallydiagnosedpulmonaryinflammatorymyofibroblastictumourwithdramaticresponsetocrizotinibinapostpartumwoman
AT adelelabbassi rarecaseofincidentallydiagnosedpulmonaryinflammatorymyofibroblastictumourwithdramaticresponsetocrizotinibinapostpartumwoman